SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Protalex, Inc. Completes Analysis of Data from Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis
Your Message